Thushan I de Silva Selected Research

Thushan I de Silva Research Topics

14	Infections 05/2022 - 09/2007
8	Human Influenza (Influenza) 12/2021 - 10/2017
3	COVID-19 05/2022 - 04/2021
3	Disease Progression 01/2019 - 01/2012
1	Coinfection 05/2022
1	Reinfection 01/2022
1	Virus Diseases (Viral Diseases) 12/2021
1	Vaccine-Preventable Diseases 01/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Multiple Sclerosis 01/2021
1	Yellow Fever 01/2019
1	Necrosis 01/2019
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018
1	Viremia 01/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 09/2007
1	Kidney Diseases (Kidney Disease) 09/2007
1	Chronic Renal Insufficiency 09/2007
1	Thrombotic Microangiopathies 09/2007
1	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 09/2007
1	Opportunistic Infections (Opportunistic Infection) 09/2007

6	VaccinesIBA 01/2022 - 01/2018
4	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2021 - 01/2018
3	InterferonsIBA 01/2022 - 01/2019
2	Immunoglobulin A (IgA)IBA 01/2019 - 10/2017
1	ProcalcitoninIBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	COVID-19 VaccinesIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Subgenomic RNAIBA 01/2022
1	AntibodiesIBA 01/2022
1	EnzymesIBA 01/2022
1	remdesivirIBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2021
1	Ferritins (Ferritin)IBA 04/2021
1	Biological ProductsIBA 04/2021
1	Hemagglutinins (Hemagglutinin)IBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 11/2019
1	AIDS VaccinesIBA 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	Interleukin-2 (IL2)IBA 01/2019
1	Panton-Valentine leukocidinIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2018
1	EpitopesIBA 12/2016
1	Immunoglobulin M (IgM)IBA 03/2015
1	Neutralizing AntibodiesIBA 01/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 09/2007
1	CytokinesIBA 09/2007

2	Therapeutics 12/2016 - 01/2011
1	Renal Dialysis (Hemodialysis) 01/2022
1	Stem Cell Transplantation 01/2021
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Contraindications 01/2018
1	Highly Active Antiretroviral Therapy (HAART) 09/2007